| Titre : |
Changing Therapies for Type 2 Diabetes |
| Type de document : |
texte imprimé |
| Auteurs : |
R David Leslie, Auteur ; Paolo Pozzilli, Auteur |
| Editeur : |
CRC Press |
| Année de publication : |
2002 |
| Autre Editeur : |
Martin Dunitz |
| ISBN/ISSN/EAN : |
978-1-84184-111-3 |
| Langues : |
Français (fre) |
| Catégories : |
Endocrinologie
|
| Résumé : |
The Seventh International Barts Symposium was held on April 20, 2001, in London. This monograph summarizes the proceedings of that conference, which shed new light on therapies used for Type 2 diabetes. The contributors are world-renowned experts in the field, and they provide incisive commentary in their respective specialties. Chapters address new developments in the administration of insulin, including oral preparations and long-acting insulin analogue. Breakthroughs in the understanding of the pathogenesis of type 2 diabetes are also discussed, along with the future of the glitazones in management. Changing Therapies for Type 2 Diabetes is essential for diabetologists, general practitioners, cardiologists, geriatricians, and specialists in internal medicine.
|
Changing Therapies for Type 2 Diabetes [texte imprimé] / R David Leslie, Auteur ; Paolo Pozzilli, Auteur . - [S.l.] : CRC Press : [S.l.] : Martin Dunitz, 2002. ISBN : 978-1-84184-111-3 Langues : Français ( fre)
| Catégories : |
Endocrinologie
|
| Résumé : |
The Seventh International Barts Symposium was held on April 20, 2001, in London. This monograph summarizes the proceedings of that conference, which shed new light on therapies used for Type 2 diabetes. The contributors are world-renowned experts in the field, and they provide incisive commentary in their respective specialties. Chapters address new developments in the administration of insulin, including oral preparations and long-acting insulin analogue. Breakthroughs in the understanding of the pathogenesis of type 2 diabetes are also discussed, along with the future of the glitazones in management. Changing Therapies for Type 2 Diabetes is essential for diabetologists, general practitioners, cardiologists, geriatricians, and specialists in internal medicine.
|
|  |
Affiner la recherche Interroger des sources externes
